These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26563552)

  • 1. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escherichia coli N-Acetylglucosamine-1-Phosphate-Uridyltransferase/Glucosamine-1-Phosphate-Acetyltransferase (GlmU) Inhibitory Activity of Terreic Acid Isolated from Aspergillus terreus.
    Sharma R; Lambu MR; Jamwal U; Rani C; Chib R; Wazir P; Mukherjee D; Chaubey A; Khan IA
    J Biomol Screen; 2016 Apr; 21(4):342-53. PubMed ID: 26762501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae.
    Buurman ET; Andrews B; Gao N; Hu J; Keating TA; Lahiri S; Otterbein LR; Patten AD; Stokes SS; Shapiro AB
    J Biol Chem; 2011 Nov; 286(47):40734-42. PubMed ID: 21984832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and optimization of Escherichia coli GlmU inhibitors: an in silico approach with validation thereof.
    Mehra R; Sharma R; Khan IA; Nargotra A
    Eur J Med Chem; 2015 Mar; 92():78-90. PubMed ID: 25544688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening identifies novel inhibitors of the acetyltransferase activity of Escherichia coli GlmU.
    Pereira MP; Blanchard JE; Murphy C; Roderick SL; Brown ED
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2306-11. PubMed ID: 19349513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of inhibitors of the bacterial cell wall synthetic enzyme GlmU using virtual screening and lead-hopping.
    Doig P; Boriack-Sjodin PA; Dumas J; Hu J; Itoh K; Johnson K; Kazmirski S; Kinoshita T; Kuroda S; Sato TO; Sugimoto K; Tohyama K; Aoi H; Wakamatsu K; Wang H
    Bioorg Med Chem; 2014 Nov; 22(21):6256-69. PubMed ID: 25262942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity.
    Parikh A; Verma SK; Khan S; Prakash B; Nandicoori VK
    J Mol Biol; 2009 Feb; 386(2):451-64. PubMed ID: 19121323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
    Tran AT; Wen D; West NP; Baker EN; Britton WJ; Payne RJ
    Org Biomol Chem; 2013 Dec; 11(46):8113-26. PubMed ID: 24158720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series.
    Green OM; McKenzie AR; Shapiro AB; Otterbein L; Ni H; Patten A; Stokes S; Albert R; Kawatkar S; Breed J
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1510-9. PubMed ID: 22297115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode.
    Larsen NA; Nash TJ; Morningstar M; Shapiro AB; Joubran C; Blackett CJ; Patten AD; Boriack-Sjodin PA; Doig P
    Biochem J; 2012 Sep; 446(3):405-13. PubMed ID: 22721802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides.
    Stokes SS; Albert R; Buurman ET; Andrews B; Shapiro AB; Green OM; McKenzie AR; Otterbein LR
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7019-23. PubMed ID: 23099094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
    Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A
    ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.
    Zhang W; Jones VC; Scherman MS; Mahapatra S; Crick D; Bhamidi S; Xin Y; McNeil MR; Ma Y
    Int J Biochem Cell Biol; 2008; 40(11):2560-71. PubMed ID: 18573680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU.
    Li Y; Zhou Y; Ma Y; Li X
    Carbohydr Res; 2011 Sep; 346(13):1714-20. PubMed ID: 21704310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis.
    Mengin-Lecreulx D; van Heijenoort J
    J Bacteriol; 1994 Sep; 176(18):5788-95. PubMed ID: 8083170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery.
    Sharma R; Khan IA
    Curr Drug Targets; 2017; 18(14):1587-1597. PubMed ID: 27138757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer.
    Jagtap PK; Soni V; Vithani N; Jhingan GD; Bais VS; Nandicoori VK; Prakash B
    J Biol Chem; 2012 Nov; 287(47):39524-37. PubMed ID: 22969087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inhibitory Effect of GlmU Acetyltransferase Inhibitor TPSA on
    Chen C; Han X; Yan Q; Wang C; Jia L; Taj A; Zhao L; Ma Y
    Front Cell Infect Microbiol; 2019; 9():251. PubMed ID: 31380295
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional GlmU protein of Escherichia coli.
    Gehring AM; Lees WJ; Mindiola DJ; Walsh CT; Brown ED
    Biochemistry; 1996 Jan; 35(2):579-85. PubMed ID: 8555230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.